Accession Number: | 0000898432-19-001323 |
Date: | 2019-11-18 |
Issuer: | IRADIMED CORP (IRMD) |
Original Submission Date: |
JOHNSON BRENT
C/O IRADIMED CORPORATION
1025 WILLA SPRINGS DR.
WINTER SPRINGS, FL 32708
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-11-18 | A | 6,000 | a | $0.93 | 7,368 | direct | ||
COMMON STOCK | 2019-11-18 | S | 6,000 | d | $22.86 | 1,368 | direct | ||
COMMON STOCK | 2019-11-19 | A | 6,000 | a | $0.93 | 7,368 | direct | ||
COMMON STOCK | 2019-11-19 | S | 6,000 | d | $23.05 | 1,368 | direct | ||
COMMON STOCK | 2019-11-20 | A | 6,000 | a | $0.93 | 7,368 | direct | ||
COMMON STOCK | 2019-11-20 | S | 6,000 | d | $23.42 | 1,368 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.93 | 2019-11-18 | deemed execution date | M | 6,000 (d) | 2021-12-27 | common stock 6,000 | $0.93 | 22,160 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 0.93 | 2019-11-19 | deemed execution date | M | 6,000 (d) | 2021-12-27 | common stock 6,000 | $0.93 | 16,160 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 0.93 | 2019-11-20 | deemed execution date | M | 6,000 (d) | 2021-12-27 | common stock 6,000 | $0.93 | 10,160 | direct |
ID | footnote |
---|---|
f1 | the exercises and sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 5, 2019. |
f2 | this transaction was executed in multiple trades at prices ranging from $22.80 to $23.07. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f3 | this transaction was executed in multiple trades at prices ranging from $23.00 to $23.36. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f4 | this transaction was executed in multiple trades at prices ranging from $23.40 to $23.55. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f5 | this option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. |